Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Theralase Technologies Inc (TLTFF)

Theralase Technologies Inc (TLTFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1052 +12.36%
on 12/15/25
0.1290 -8.37%
on 12/12/25
+0.0054 (+4.79%)
since 11/28/25
3-Month
0.1019 +16.00%
on 11/25/25
0.1595 -25.89%
on 10/13/25
-0.0173 (-12.77%)
since 09/29/25
52-Week
0.1019 +16.00%
on 11/25/25
0.2400 -50.75%
on 01/06/25
-0.0598 (-33.60%)
since 12/27/24

Most Recent Stories

More News
Theralase(R) Closes $1.3 M Non-Brokered Private Placement

Toronto, Ontario--(Newsfile Corp. - December 23, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering...

TLT.VN : 0.160 (unch)
TLTFF : 0.1182 (-5.21%)
Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing

Toronto, Ontario--(Newsfile Corp. - December 12, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering...

TLT.VN : 0.160 (unch)
TLTFF : 0.1182 (-5.21%)
Theralase(R) Investor Conference Call Reminder

Theralase(R) Reminds Investors of Conference Call to Provide Update on Study II Interim Data Demonstrating 64.3% Complete ResponseToronto, Ontario--(Newsfile Corp. - November 17, 2025) - Theralase® Technologies...

TLT.VN : 0.160 (unch)
TLTFF : 0.1182 (-5.21%)
Theralase(R) Releases 3Q2025 Financial Statements

Toronto, Ontario--(Newsfile Corp. - November 10, 2025) - Theralase® Technologies Inc. (TSXV:TLT) (OTCQB:TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering light, radiation,...

TLT.VN : 0.160 (unch)
TLTFF : 0.1182 (-5.21%)
Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug

Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light,...

TLT.VN : 0.160 (unch)
TLTFF : 0.1182 (-5.21%)
Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus

Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering...

TLT.VN : 0.160 (unch)
TLTFF : 0.1182 (-5.21%)
Theralase(R) Extends Warrants

Toronto, Ontario--(Newsfile Corp. - August 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light,...

TLT.VN : 0.160 (unch)
TLTFF : 0.1182 (-5.21%)
Theralase(R) Releases 2Q2025 Financial Statements

Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering light, radiation,...

TLT.VN : 0.160 (unch)
TLTFF : 0.1182 (-5.21%)
Theralase(R) Closes Non-Brokered Private Placement

Toronto, Ontario--(Newsfile Corp. - July 28, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light,...

TLT.VN : 0.160 (unch)
TLTFF : 0.1182 (-5.21%)
Theralase(R) Extends Warrants

Toronto, Ontario--(Newsfile Corp. - June 27, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light,...

TLT.VN : 0.160 (unch)
TLTFF : 0.1182 (-5.21%)

Key Turning Points

3rd Resistance Point 0.1241
2nd Resistance Point 0.1226
1st Resistance Point 0.1204
Last Price 0.1182
1st Support Level 0.1167
2nd Support Level 0.1152
3rd Support Level 0.1130

See More

52-Week High 0.2400
Fibonacci 61.8% 0.1872
Fibonacci 50% 0.1709
Fibonacci 38.2% 0.1547
Last Price 0.1182
52-Week Low 0.1019

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar